No Data
Viiv's Dovato as Effective as Gilead' Biktarvy for HIV but With Less Weight Gain
Gilead Sciences (GILD) Receives a Buy From TD Cowen
TD Cowen Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $85
Wells Fargo Maintains Gilead Sciences(GILD.US) With Hold Rating, Maintains Target Price $78
Analysts' Opinions Are Mixed on These Healthcare Stocks: IQVIA Holdings (IQV), Vertex Pharmaceuticals (VRTX) and Gilead Sciences (GILD)
Gilead Sciences: A Balanced Outlook With Steady HIV Performance and Oncology Challenges Justifying a Hold Rating
Supermengg :
103397071 : good
73958256 : translate
Paul Anthony : visit Singapore coming up
Paul Anthony : for young people with this learn about the best person in charge A1 Amen together